A1M Pharma initiates research collaboration with Fred Hutchinson Cancer Research Centre on the mechanisms of action of the protein A1M
A1M Pharma has signed a sponsored research collaboration agreement with the world-renowned Fred Hutchinson Cancer Research Centre in Seattle, USA, whose scientists include three Nobel laurates. The purpose of the collaboration is to elucidate molecular and tissue-specific mechanisms of action of the endogenous protein A1M.Within the frame of the collaboration, the internationally renowned nephrologist and researcher Dr Richard Zager of Fred Hutchinson Cancer Research Centre will be working closely with A1M scientists to broaden the knowledge of molecular and tissue-specific mechanisms of